SCHEMBL6979175

SCHEMBL6979175

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C(=O)OC)cc1C(=N)N)S(=O)(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.39
PDK1 Q15118 2/20 0.39
PDK2 Q15119 2/20 0.39
PDK3 Q15120 2/20 0.39
PDK4 Q16654 2/20 0.39
MAPK1 P28482 1/20 0.39
POLB P06746 2/20 0.38
LMNA P02545 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 1/20 0.37
NR3C1 P04150 1/20 0.37
TSHR P16473 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984846 0.91 USP2 (0.38) USP2PDK1PDK2PDK3PDK4
SCHEMBL6980895 0.89 PDK1 (0.40) USP2PDK1PDK2PDK3PDK4
SCHEMBL6984481 0.87 F2 (0.41) PDK1PDK2PDK3PDK4POLB
SCHEMBL6978636 0.87 PDK1 (0.36) USP2PDK1PDK2PDK3PDK4
SCHEMBL6985778 0.86 NR3C1 (0.43) USP2PDK1PDK2PDK3PDK4
SCHEMBL7089640 0.85 PDK1 (0.36) PDK1PDK2PDK3PDK4POLB
SCHEMBL7960545 0.83 F2 (0.44) PDK1PDK2PDK3PDK4LMNA
SCHEMBL6979171 0.83 USP2 (0.41) USP2PDK1PDK2PDK3PDK4
SCHEMBL6981264 0.81 NR3C1 (0.48) POLBLMNAALDH1A1HPGDNPSR1
SCHEMBL6978188 0.80 LMNA (0.54) USP2LMNAALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed